The 50:50 mixing study
What it is
The mixing study is done on a prolonged APTT. A 1:1 mix of the patient with a control is made, and the APTT of that mix is taken twice, at 0 hours and again at 2 hours, alongside the patient's own APTT and the control's APTT. One described set of results: an APTT of 68 seconds against a control's APTT of 36s, with the 1:1 mix 68s at 0 hours and 65s at 2 hours, that is, a mix that shows no correction. The rest of the coagulation screen is read with it, and in that same set the other values were normal: a PT of 11 seconds against a normal range of 9-12s, an APTT of 68 seconds against a normal range of 28-40s, a thrombin time of 16 seconds against a normal range of 12-18s, and a fibrinogen of 2.5 g/L against a normal range of 1.7-3.6 g/L.
Causes and risk
The study is asked for because an isolated prolonged PTT has a short list of causes: deficiency of a coagulation factor in the intrinsic pathway, contact factor deficiency, and a circulating anticoagulant, that is an inhibitor, of which lupus anticoagulant is the named example. When the PT is prolonged alongside the PTT the list is a different one: massive transfusion of PRBC, disseminated intravascular coagulation, liver disease, direct thrombin inhibitors, thrombolysis, combined factor deficiency, and common pathway factor deficiency.
How it is diagnosed
The result is read against five causes of a prolonged APTT:
- Acquired hemophilia A, a factor VIII inhibitor: typically prolongs the APTT alone with a normal PT, often presents with spontaneous bleeding, and the mixing study shows no correction.
- Antiphospholipid antibodies: the lupus anticoagulant can prolong the APTT, usually does not cause bleeding and may cause thrombosis instead, and the mixing study usually shows partial correction, sometimes time-dependent.
- Heparin contamination: prolongs the APTT, and the thrombin time may also be prolonged, so a normal thrombin time makes it unlikely.
- Von Willebrand disease: may mildly prolong the APTT if factor VIII is low, and usually corrects with the mixing study.
- Warfarin therapy: prolongs the PT and INR, not the APTT alone.
So a mix that corrects and a mix that does not correct point in different directions, and the second reading at 2 hours matters, because a correction that is only partial or only time-dependent tells its own story. In the described set the mix shows no correction while the PT and the thrombin time are normal, and that fits acquired hemophilia A, the factor VIII inhibitor.
The rule under all of that is one line. The mixing study is performed when the PTT is prolonged, to differentiate between an intrinsic factor deficiency and an inhibitor, whether a FVIII inhibitor or lupus. 50% of the patient plasma is mixed with 50% of normal plasma, and the PTT of the mix is then tested. If the PTT is corrected, that is normal, after mixing, it is a factor deficiency. If the PTT does not correct and is still prolonged after mixing, it is a factor inhibitor. So a mix that corrects points to a deficiency, and a mix that stays prolonged points to an inhibitor.